Individualized approach to primary prevention of substance use disorder: age-related risks

Eric Afuseh, Caitlin A Pike, Ukamaka M Oruche, Eric Afuseh, Caitlin A Pike, Ukamaka M Oruche

Abstract

Background: The misuse of legal and illegal substances has led to an increase in substance use disorder (SUD) in the United States. Although primary prevention strategies have been successfully used to target chronic physical diseases, these strategies have been less effective with SUD, given misconceptions of SUD, shortages in behavioral health professionals, and the population-based focus on specific substances. A developmental approach to the identification and primary prevention of SUD that does not fully rely upon behavioral health workers is needed. The purpose of this paper was to examine age related risk factors for developing SUD and present a novel individualized approach to SUD prevention.

Methods: A literature search was conducted to identify risk factors for SUD among children, young adults, adults, and older adults. We searched CINAHL, PsycINFO, and PubMed between the years 1989-2019, and extracted data, analyzing similarities and differences in risk factors across life stages. Broader categories emerged that were used to group the risk factors.

Results: More than 370 articles were found. Across all age groups, risk factors included adverse childhood experiences, trauma, chronic health diseases, environmental factors, family history, social determinants, and grief and loss. Despite the similarities, the contextual factors and life challenges associated with these risks varied according to the various life stages. We proposed an approach to primary prevention of SUD based on risk factors for developing the disease according to different age groups. This approach emphasizes screening, education, and empowerment (SEE), wherein individuals are screened for risk factors according to their age group, and screening results are used to customize interventions in the form of education and empowerment. Given that trained persons, including non-healthcare providers, close to the at-risk individual could conduct the screening and then educate and mentor the individual according to the risk level, the number of people who develop SUD could decrease.

Conclusions: The risk factors for developing SUD vary across the various life stages, which suggests that individualized approaches that do not overtax behavioral healthcare workers are needed. Using SEE may foster early identification and individualized prevention of SUD.

Keywords: Opioid; Primary prevention; Risk factors; Substance misuse; Substance use disorder.

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Vasilenko SA, Evans-Polce RJ, Lanza ST. Age trends in rates of substance use disorders across ages 18-90: differences by gender and race/ethnicity. Drug Alcohol Depend. 2017;180:260–264.
    1. Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health. Ann Intern Med. 2017;167(5):293–301.
    1. Substance Abuse and Mental Health Services Administration . Results from the 2012 national survey on drug use and health: summary of national findings. NSDUH series H-46. HHS publication no. (SMA) 13–4795. Rockville: Substance Abuse and Mental Health Services Administration; 2013.
    1. National Institute of Drug Abuse. National Institute of Drug Abuse: Commonly Abused Drugs Charts. . Accessed 1 Dec 2019.
    1. Okie S. A flood of opioids, a rising tide of deaths [published correction appears in N Engl J med. 2011 Jan 20;364(3):290] N Engl J Med. 2010;363(21):1981–1985.
    1. Choi NG, DiNitto DM, Marti CN, Choi BY. Adults who misuse opioids: substance abuse treatment use and perceived treatment need. Subst Abus. 2019;40(2):247–255.
    1. Johnson K, Rigg KK, Hopkins EC. Receiving addiction treatment in the US: do patient demographics, drug of choice, or substance use disorder severity matter? Int J Drug Policy. 2020;75:102583.
    1. McLellan AT, Lewis DC, O'Brien CP, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689–1695.
    1. McLellan AT, Starrels JL, Tai B, et al. Can substance use disorders be managed using the chronic care model? Review and recommendations from a NIDA consensus group. Public Health Rev. 2013;35(8).
    1. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34.
    1. Venditti EM. Behavioral lifestyle interventions for the primary prevention of type 2 diabetes and translation to Hispanic/Latino communities in the United States and Mexico. Nutr Rev. 2017;75(suppl 1):85–93.
    1. Guerrero EG, Padwa H, Serret V, Rico M, Hunter S, Gelberg L. Program capacity to deliver prevention services to children of adult clients receiving substance use disorder treatment. J Prim Prev. 2019;40(3):343–355.
    1. Compton WM, Jones CM, Baldwin GT, Harding FM, Blanco C, Wargo EM. Targeting youth to prevent later substance use disorder: an underutilized response to the US opioid crisis. Am J Public Health. 2019;109(S3):S185–S189.
    1. Kristjansson AL, Mann MJ, Smith ML. Prevalence of substance use among middle school-aged e-cigarette users compared with cigarette smokers, nonusers, and dual users: implications for primary prevention. Subst Abus. 2017;38(4):473–476.
    1. Substance Abuse and Mental Health Services Administration . Selecting best-fit programs and practices: guidance for substance misuse prevention practitioners. 2018.
    1. Bishop TF, Seirup JK, Pincus HA, Ross JS. Population of US practicing psychiatrists declined, 2003-13, which may help explain poor access to mental health care. Health Aff (Millwood) 2016;35(7):1271–1277.
    1. Johnson K, Collins D, Shamblen S, Kenworthy T, Wandersman A. Long-term sustainability of evidence-based prevention interventions and community coalitions survival: a five and one-half year follow-up study. Prev Sci. 2017;18(5):610–621.
    1. Salas-Wright CP, AbiNader MA, Vaughn MG, et al. Trends in substance use prevention program participation among adolescents in the U.S. J Adolesc Health. 2019;65(3):426–429.
    1. Caputi TL, McLellan AT. Truth and D.A.R.E.: Is D.A.R.E.’s new Keepin’ it REAL curriculum suitable for American nationwide implementation? Drugs Educ Prev Policy. 2017;24(1):49–57.
    1. Skara S, Sussman S. A review of 25 long-term adolescent tobacco and other drug use prevention program evaluations. Prev Med. 2003;37(5):451–474.
    1. Stein MD, Conti MT, Kenney S, et al. Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder. Drug Alcohol Depend. 2017;179:325–329.
    1. Douglas KR, Chan G, Gelernter J, et al. Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. Addict Behav. 2010;35(1):7–13.
    1. McDonald TP, Mariscal ES, Yan Y, Brook J. Substance use and abuse for youths in foster care: results from the communities that care normative database. J Child Adolesc Subst Abuse. 2014;23(4):262–268.
    1. Russell BS, Trudeau JJ, Leland AJ. Social influence on adolescent polysubstance use: the escalation to opioid use. Subst Use Misuse. 2015;50(10):1325–1331.
    1. Veliz P, Boyd CJ, McCabe SE. Nonmedical use of prescription opioids and heroin use among adolescents involved in competitive sports. J Adolesc Health. 2017;60(3):346–349.
    1. Broman CL. The availability of substances in adolescence: influences in emerging adulthood. J Child Adolesc Subst Abuse. 2016;25(5):487–495.
    1. Cardoso JB, Szlyk HS, Goldbach J, Swank P, Zvolensky MJ. General and ethnic-biased bullying among Latino students: exploring risks of depression, suicidal ideation, and substance use. J Immigr Minor Health. 2018;20(4):816–822.
    1. Kecojevic A, Jun HJ, Reisner SL, Corliss HL. Concurrent polysubstance use in a longitudinal study of US youth: associations with sexual orientation. Addiction. 2017;112(4):614–624.
    1. Day JK, Fish JN, Perez-Brumer A, Hatzenbuehler ML, Russell ST. Transgender youth substance use disparities: results from a population-based sample. J Adoles Health. 2017;61(6):729–735.
    1. Lightfoot M, Wu N, Hughes S, Desmond K, Tevendale H, Stevens R. Risk factors for substance use among youth experiencing homelessness. J Child Adolesc Subst Abuse. 2018;27(5–6):288–296.
    1. Santa Maria DM, Narendorf SC, Cross MB. Prevalence and correlates of substance use in homeless youth and young adults. J Addict Nurs. 2018;29(1):23–31.
    1. Allen HK, Caldeira KM, Bugbee BA, Vincent KB, O'Grady KE, Arria AM. Drug involvement during and after college: estimates of opportunity and use given opportunity. Drug Alcohol Depend. 2017;174:150–157.
    1. Katirai W, Williams C, Katirai M, Fyalkowski S. The relationship between depression, stress, and alcohol, tobacco and other drugs (ATOD) among college students from 2010-2015. Educ Health. 2018;36(4):91–98.
    1. Harbaugh CM, Nalliah RP, Hu HM, Englesbe MJ, Waljee JF, Brummett CM. Persistent opioid use after wisdom tooth extraction. JAMA. 2018;320(5):504–506.
    1. Ford JA, Pomykacz C, Veliz P, McCabe SE, Boyd CJ. Sports involvement, injury history, and non-medical use of prescription opioids among college students: an analysis with a national sample. Am J Addict. 2018;27(1):15–22.
    1. Alunni-Kinkle S. Identifying substance use disorder in nursing. Nurs Manag. 2015;46(12):53–54.
    1. Linn B. Comorbid posttraumatic stress symptoms and substance use in veterans: Latent class analysis and path analysis considering the effects of pre-service variables (Doctoral dissertation, State University of New York at Buffalo).
    1. Krill PR, Johnson R, Albert L. The prevalence of substance use and other mental health concerns among American attorneys. J Addict Med. 2016;10(1):46–52.
    1. Cottler LB, Abdallah AB, Cummings SM, Barr J, Banks R, Forchheimer R. Injury, pain, and prescription opioid use among former National Football League (NFL) players. Drug Alcohol Depend. 2011;116(1–3):188–194.
    1. Furr SR, Johnson WD, Goodall CS. Grief and recovery: the prevalence of grief and loss in substance abuse treatment. J Addict Offender Couns. 2015;36(1):43–56.
    1. Culberson JW, Ticker RL, Burnett J, Marcus MT, Pickens SL, Dyer CB. Prescription medication use among self neglecting elderly. J Addict Nurs. 2011;22(1–2):63–68.
    1. Blanco C, Wall MM, Okuda M, Wang S, Iza M, Olfson M. Pain as a predictor of opioid use disorder in a nationally representative sample. Am J Psychiatry. 2016;173(12):1189–1195.
    1. Children’s Bureau. Adverse Childhood Experiences (ACEs). Available from: . Accessed 29 April 2020.
    1. Strine TW, Dube SR, Edwards VJ, Prehn AW, Rasmussen S, Wagenfeld M, Dhingra S, Croft JB. Associations between adverse childhood experiences, psychological distress, and adult alcohol problems. Am J Health Behav. 2012;36(3):408–423.
    1. Rose SM, Xie D, Stineman M. Adverse childhood experiences and disability in US adults. PM R. 2014;6(8):670–680.
    1. Campbell JA, Walker RJ, Egede LE. Associations between adverse childhood experiences, high-risk behaviors, and morbidity in adulthood. Am J Prev Med. 2016;50(3):344–352.
    1. Gilbert LK, Breiding MJ, Merrick MT, Parks SE, Thompson WW, Dhingra SS, Ford DC. Childhood adversity and adult chronic disease: an update from ten states and the District of Columbia, 2010. Am J Prev Med. 2015;48(3):345–349.
    1. Fuller-Thomson E, Baird SL, Dhrodia R, Brennenstuhl S. The association between adverse childhood experiences (ACEs) and suicide attempts in a population-based study. Child Care Health Dev. 2016;42(5):725–734.
    1. Cole J, Sprang G, Silman M. Interpersonal trauma exposure, trauma symptoms, and severity of substance use disorder among youth entering outpatient substance abuse treatment. J Child Adolesc Trauma. 2019;12(3):341–349.
    1. Quinn ST, Stewart MC. Examining the long-term consequences of bullying on adult substance use. Am J Crim Justice. 2018;43(1):85–101.
    1. Earnshaw VA, Elliott MN, Reisner SL, Mrug S, Windle M, Emery ST, Peskin MF, Schuster MA. Peer victimization, depressive symptoms, and substance use: a longitudinal analysis. Pediatrics. 2017;139(6):e20163426.
    1. Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012;172(5):425–430.
    1. Chasser YM. Profiles of youths with PTSD and addiction. J Child Adolesc Subst Abuse. 2016;25(5):448–454.
    1. Weitzman ER, Salimian PK, Rabinow L, Levy S. Perspectives on substance use among youth with chronic medical conditions and implications for clinical guidance and prevention: A qualitative study. PloS One. 2019;14(1):e0209963.
    1. Ho P, Rosenheck R. Substance use disorder among current cancer patients: rates and correlates nationally in the Department of Veterans Affairs. Psychosomatics. 2018;59(3):267–276.
    1. Mechcatie E. Duration of postoperative opioid use predicts misuse more than dosage. Am J Nurs. 2018;118(4):15.
    1. Veliz P, Epstein-Ngo QM, Meier E, Ross-Durow PL, McCabe SE, Boyd CJ. Painfully obvious: a longitudinal examination of medical use and misuse of opioid medication among adolescent sports participants. J Adolesc Health. 2014;54(3):333–340.
    1. Powers G, Berger L, Fuhrmann D, Fendrich M. Family history density of substance use problems among undergraduate college students: associations with heavy alcohol use and alcohol use disorder. Addict Behav. 2017;71:1–6.
    1. Richmond-Rakerd LS, Slutske WS, Lynskey MT, Agrawal A, Madden PA, Bucholz KK, et al. Age at first use and later substance use disorder: shared genetic and environmental pathways for nicotine, alcohol, and cannabis. J Abnorm Psychol. 2016;125(7):946.
    1. Blum K, Lott L, Siwicki D, Fried L, Hauser M, Simpatico T, Baron D, Howeedy A, Badgaiyan RD. Genetic Addiction Risk Score (GARS™) as a predictor of substance use disorder: Identifying predisposition not diagnosis. Curr Trends Med Diagn Meth. 2018;1(1). 10.29011/CTMDM-101.100001.
    1. Cerdá M, Bordelois P, Keyes KM, et al. Family ties: maternal-offspring attachment and young adult nonmedical prescription opioid use. Drug Alcohol Depend. 2014;142:231–238.
    1. Garbutt JM, Kulka K, Dodd S, Sterkel R, Plax K. Opioids in adolescents’ homes: prevalence, caregiver attitudes, and risk reduction opportunities. Acad Pediatr. 2019;19(1):103–108.
    1. Prince JD. Opioid analgesic use disorders among adolescents in the United States. J Child Adolesc Subst Abuse. 2015;24(1):28–36.
    1. Garrett BA, Livingston BJ, Livingston MD, Komro KA. The effects of perceived racial/ethnic discrimination on substance use among youths living in the Cherokee nation. J Child Adolesc Subst Abuse. 2017;26(3):242–249.
    1. Compton WM, Gfroerer J, Conway KP, Finger MS. Unemployment and substance outcomes in the United States 2002-2010. Drug Alcohol Depend. 2014;142:350–353.
    1. Crum RM. Educational achievement and early school behavior as predictors of alcohol-use disorders: 35-year follow-up of the Woodlawn study. J Stud Alcohol. 2006;67:75–85.
    1. Masferrer L, Garre-Olmo J, Caparrós B. Is complicated grief a risk factor for substance use? A comparison of substance-users and normative grievers. Addict Res Theory. 2017;25(5):361–367.
    1. Otowa T, York TP, Gardner CO, Kendler KS, Hettema JM. The impact of childhood parental loss on risk for mood, anxiety and substance use disorders in a population-based sample of male twins. Psychiatry Res. 2014;220(1–2):404–409.
    1. Choi NG, Kimbell K. Depression care need among low-income older adults: views from aging service providers and family caregivers. Clin Gerontol. 2008;32(1):60–76.
    1. Brooks JM, Petersen C, Kelly SM, Reid MC. Likelihood of depressive symptoms in us older adults by prescribed opioid potency: national health and nutrition examination survey 2005-2013. Int J Geriatr Psychiatry. 2019;34(10):1481–1489.
    1. Daniels-Witt Q, Thompson A, Glassman T, Federman S, Bott K. The case for implementing the levels of prevention model: opiate abuse on American college campuses. J Am Coll Heal. 2017;65(7):518–524.
    1. Halsted CE. Improper disposal of prescription opioids among young adults. Am J Public Health. 2018;108(11):1492–1493.
    1. Avant EM, Davis JL, Cranston CC. Posttraumatic stress symptom clusters, trauma history, and substance use among college students. J Aggression Maltreatment Trauma. 2011;20(5):539.
    1. Boulton MA, O'Connell KA. Past year substance use by student nurses. J Addict Nurs. 2017;28(4):179–187.
    1. Bozimowski G, Groh C, Rouen P, Dosch M. The prevalence and patterns of substance abuse among nurse anesthesia students. AANA J. 2014;82(4):277–283.
    1. Harries MD, Lust K, Christenson GA, Redden SA, Grant JE. Prescription opioid medication misuse among university students. Am J Addict. 2018. 10.1111/ajad.12807.
    1. Kelley ML, Bravo AJ, Hamrick HC, Braitman AL, Judah MR. Killing during combat and negative mental health and substance use outcomes among recent-era veterans: the mediating effects of rumination. Psychol Trauma. 2019;11(4):379.
    1. Rhee TG, Rosenheck RA. Comparison of opioid use disorder among male veterans and non-veterans: Disorder rates, socio-demographics, co-morbidities, and quality of life. Am J Addict. 2019;28(2):92–100. doi: 10.1111/ajad.12861.
    1. Evans, G. Employee health programs stepping up on drug diversion. Available from: . Accessed 30 April 2020.
    1. Kunyk D, Milner M, Overend A. Disciplining virtue: investigating the discourses of opioid addiction in nursing. Nurs Inq. 2016;23(4):315–326.
    1. Merlo LJ, Cummings SM, Cottler LB. Recovering substance-impaired pharmacists’ views regarding occupational risks for addiction. J Am Pharm Assoc (2003) 2012;52(4):480–491.
    1. Bryson EO, Silverstein JH. Addiction and substance abuse in anesthesiology. Anesthesiology. 2008;109(5):905–917.
    1. Domino KB, Hornbein TF, Polissar NL, Renner G, Johnson J, Alberti S, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA. 2005;293(12):1453–1460.
    1. Warner DO, Berge K, Sun H, Harman A, Hanson A, Schroeder DR. Substance use disorder among anesthesiology residents, 1975-2009. JAMA. 2013;310(21):2289–2296.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться